5 accepted papers
Virtual screening (VS) aims to identify bioactive compounds from vast chemical libraries, but remains difficult in low-label regimes where only a few actives are known. Existing methods largely rely on general-purpose molecular fingerprints and overlook class-discriminative substructures critical to…
The advent of generative AI now enables large-scale $\textit{de novo}$ design of molecules, but identifying viable drug candidates among them remains an open problem. Existing drug-likeness prediction methods often rely on ambiguous negative sets or purely structural features, limiting their ability…
Accurately predicting protein-ligand binding affinity is a critical challenge in drug discovery, crucial for understanding drug efficacy. While existing models typically rely on atom-level interactions, they often fail to capture the complex, higher-order interactions, resulting in noise and computa…
Out-of-distribution (OOD) generalization in the graph domain is challenging due to complex distribution shifts and a lack of environmental contexts. Recent methods attempt to enhance graph OOD generalization by generating flat environments. However such flat environments come with inherent limitatio…
Recently, graph neural networks (GNNs) have been widely used for document classification. However, most existing methods are based on static word co-occurrence graphs without sentence-level information, which poses three challenges:(1) word ambiguity, (2) word synonymity, and (3) dynamic contextual…